Enhancing Hematological Parameters and Alleviating Complaints in Transfusion-Dependent Thalassemic patients
Main Article Content
Abstract
Objective: To investigate the potential benefits of using supplements, such as folic acid, vitamin E, and calcium, to improve certain hematological parameters and overall well-being in patients with beta-thalassemia.
Methodology: This quasi-experimental study included 277 transfusion-dependent beta thalassemia major patients aged 20-38 from 20th January-30th April 2024. Patients received at least one transfusion per month and presented symptoms like lethargy, fatigue, breathlessness, bone pain, brittle hair and nails. They were prescribed daily oral supplements: Folic Acid (5mg), Vitamin E (200mg), Calcium (500mg) with Vitamin D3 (400IU), and Magnesium (150mg). Patients were monitored every 15 days for symptom improvements. Blood samples were collected before each transfusion. Hematological parameters like hematocrit, hemoglobin levels, White Blood Cells (WBCs), Red Blood Cells (RBCs) and platelets were recorded. Hematological parameters before initiation of supplements and at 3 month follow-up were compared using paired t test.
Results: The results showed a significant increase in hemoglobin, hematocrit, RBCs, and platelets after the intervention. Mean hemoglobin improved from 8.284 to 8.651, with increase of 0.367 units (95% CI: 0.24336 to 0.4904). MCV increased by 0.4224, and MCH by 0.2365, both statistically significant (p = 0.047 and p = 0.007, respectively). The generalized complaints reduced considerably in these patients.
Conclusion: The study showed that prescribed supplements significantly improved hematological parameters in these patients and reduced their clinical complaints.
Article Details
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
References
Shafique F, Ali S, Almansouri T, Van Eeden F, Shafi N, Khalid M, et al. Thalassemia, a human blood disorder. Braz J Biol 2021;83: e246062. DOI: 10.1590/1519-6984.246062.
Al-Moshary M, Al-Mussaed E, Khan A. Prevalence of transfusion transmitted infections and the quality of life in beta-thalassemia major patients. Cureus 2019;11(11): e6129.
Khaliq S. Thalassemia in Pakistan. Hemoglobin 2022;46(1):12-4.
Ansari SH, Shamsi TS, Ashraf M, Bohray M, Farzana T, Khan MT, et al. Molecular epidemiology of beta-thalassemia in Pakistan: far reaching implications. Int J Mol Epidemiol Genet 2011;2(4):403-8.
Ahmed S, Jafri H, Rashid Y, Ehsan Y, Bashir S, Ahmed M. Cascade screening for beta-thalassemia in Pakistan: development, feasibility and acceptability of a decision support intervention for relatives. Eur J Hum Genet 2022;30(1):73-80. DOI: 10.1038/s41431-021-00918-6.
d'Arqom A, G Putri M, Savitri Y, Rahul Alfaidin AM. Vitamin and mineral supplementation for beta-thalassemia during COVID-19 pandemic. Future Sci OA 2020;6(9): FSO628. DOI: 10.2144/fsoa-2020-0110.
Singla H, GG. Role of estimation of serum ferritin, vitamin B12, and folic acid in the management of beta-thalassemic children. Int J Med Res Rev 2016;4(8):1476-83.
Karimi M, Cohan N, De Sanctis V. Thalassemia intermedia; folic acid and vitamin B12 supplementation: What we know and what is needed? Iran J Ped Hematol Oncol 2017;7(1):57-62.
Mojtahedzadeh F, Kosaryan M, Mahdavi MR, Akbari J. The effect of folic acid supplementation in beta-thalassemia major: A randomized placebo-controlled clinical trial. Arch Iran Med 2006;9(3):266-8.
Goyal M, Abrol P, Lal H. Parathyroid and calcium status in patients with thalassemia. Indian J Clin Biochem 2010;25(4):385-7.
Lewis ED, Meydani SN, Wu D. Regulatory role of vitamin E in the immune system and inflammation. IUBMB Life 2019;71(4):487-94.
Rachmilewitz EA, Shifter A, Kahane I. Vitamin E deficiency in beta-thalassemia major: Changes in hematological and biochemical parameters after a therapeutic trial with alpha-tocopherol. Am J Clin Nutr 1979;32(9):1850-8.
Cárdenas EMB. Bioinformatic analysis of insertion, deletion, and substitution mutations in the human beta-globin gene. Comput Mol Biosci 2021;11(1).
Green R, Datta Mitra A. Megaloblastic anemias: Nutritional and other causes. Med Clin North Am 2017;101(2):297-317.
Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009;9(11):799-809.
Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352(10):1011-23.
Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta 2012;1823(9):1434-43.
Means RT Jr. Pathogenesis of the anemia of chronic disease: A cytokine-mediated anemia. Stem Cells 1995;13(1):32-7.
Taher AT, Cappellini MD, Musallam KM. Recent advances and treatment challenges in patients with non-transfusion-dependent thalassemia. Blood Rev 2012;26 Suppl 1: S1-2.
Tripathi G, Kalra M, Mahajan A. Folate supplementation in transfusion-dependent thalassemia: Do we really need such high doses? Indian J Med Paediatr Oncol 2016;37(4):305.
Williams BA, McCartney H, Adams E, Devlin AM, Singer J, Vercauteren S, et al. Folic acid supplementation in children with sickle cell disease: Study protocol for a double-blind randomized cross-over trial. Trials 2020;21(1):593.
Bove-Fenderson E, Mannstadt M. Hypocalcemic disorders. Best Pract Res Clin Endocrinol Metab 2018;32(5):639-56.
Nagy M, Mastenbroek TG, Mattheij NJA, de Witt S, Clemetson KJ, Kirschner J, et al. Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies. Haematologica 2018;103(3):540-9.
Santra S, Sharma K, Dash I, Mondal S, Mondal H. Bone mineral density, serum calcium, and vitamin D levels in adult thalassemia major patients: Experience from a single center in Eastern India. Cureus 2022;14(7): e26688.
Stefanopoulos D, Papaioannou NA, Papavassiliou AG, Mastorakos G, Vryonidou A, Michou A, et al. A contemporary therapeutic approach to bone disease in beta-thalassemia: A review. J Frailty Sarcopenia Falls 2018;3(1):13-25.
Jilani T, Iqbal MP. Vitamin E deficiency in South Asian population and the therapeutic use of alpha-tocopherol (Vitamin E) for correction of anemia. Pak J Med Sci 2018;34(6):1571-5.
Violi F, Pignatelli P, Basili S. Nutrition, supplements, and vitamins in platelet function and bleeding. Circulation 2010;121(8):1033-44.
Rizvi S, Raza ST, Ahmed F, Ahmad A, Abbas S, Mahdi F. The role of vitamin E in human health and some diseases. Sultan Qaboos Univ Med J 2014;14(2):e157-65.
Pronai W, Riegler-Keil M, Silberbauer K, Stockenhuber F. Folic acid supplementation improves erythropoietin response. Nephron 1995;71(4):395-400.
Traber MG, Atkinson J. Vitamin E: Antioxidant and nothing more. Free Radic Biol Med 2007;43(1):4-15.
Socha DS, DeSouza SI, Flagg A, Sekeres M, Rogers HJ. Severe megaloblastic anemia: Vitamin deficiency and other causes. Cleve Clin J Med 2020;87(3):153-64. DOI: 10.3949/ccjm.87a.19072.